Ischemic proctitis after low-dose-rate brachytherapy using hydrogel spacer for prostate cancer.
brachytherapy
hydrogels
ischemic colitis
proctitis
prostatic neoplasms
Journal
IJU case reports
ISSN: 2577-171X
Titre abrégé: IJU Case Rep
Pays: Australia
ID NLM: 101764958
Informations de publication
Date de publication:
Jul 2022
Jul 2022
Historique:
received:
17
02
2022
revised:
08
03
2022
accepted:
19
03
2022
entrez:
7
7
2022
pubmed:
8
7
2022
medline:
8
7
2022
Statut:
epublish
Résumé
Recently, an absorbable hydrogel spacer is becoming more widespread to reduce rectal radiation dose for radiation therapy for localized prostate cancer. A 79-year-old male patient was referred to our hospital for radical treatment of organ-confined prostate cancer. Low-dose-rate brachytherapy was performed, and the hydrogel spacer injection was added. The spacer was properly injected between the prostate and the rectum, causing no acute complications during hospitalization. Two months after low-dose-rate brachytherapy, the patient visited our hospital with constipation and melena, without fever. He was diagnosed with ischemic proctitis based on clinical courses and examinations. He was hospitalized for 19 days and made a complete recovery with conservative treatment. Herein, we report the first case of ischemic proctitis after low-dose-rate brachytherapy using hydrogel spacer for prostate cancer.
Identifiants
pubmed: 35795104
doi: 10.1002/iju5.12444
pii: IJU512444
pmc: PMC9249642
doi:
Types de publication
Case Reports
Langues
eng
Pagination
237-240Informations de copyright
© 2022 The Authors. IJU Case Reports published by John Wiley & Sons Australia, Ltd on behalf of the Japanese Urological Association.
Déclaration de conflit d'intérêts
The authors declare no conflict of interest.
Références
Int J Radiat Oncol Biol Phys. 2010 Feb 1;76(2):355-60
pubmed: 19632069
Int J Radiat Oncol Biol Phys. 2011 Apr 1;79(5):1336-42
pubmed: 20605342
World J Gastroenterol. 2008 Dec 28;14(48):7302-8
pubmed: 19109863
Clin Gastroenterol Hepatol. 2019 Jan;17(1):8-15
pubmed: 29601902
BMJ Case Rep. 2014 Dec 22;2014:
pubmed: 25535226
Dig Dis Sci. 2018 Sep;63(9):2180-2188
pubmed: 29948565
World J Urol. 2021 Jun;39(6):1769-1780
pubmed: 32840655
Int J Clin Oncol. 2018 Dec;23(6):1148-1159
pubmed: 29934842
ANZ J Surg. 2018 Apr;88(4):278-283
pubmed: 29124893
Urology. 2021 Oct;156:e74-e85
pubmed: 34029607
Curr Gastroenterol Rep. 2020 Aug 24;22(11):54
pubmed: 32839874
Int J Radiat Oncol Biol Phys. 2015 Aug 1;92(5):971-977
pubmed: 26054865
Brachytherapy. 2012 Jul-Aug;11(4):245-9
pubmed: 21925957
Int J Urol. 2020 Jan;27(1):60-66
pubmed: 31587417
Brachytherapy. 2021 Mar-Apr;20(2):296-301
pubmed: 33199175
BMC Cancer. 2017 Aug 25;17(1):573
pubmed: 28841855
World J Gastroenterol. 2007 Feb 28;13(8):1236-9
pubmed: 17451205
Brachytherapy. 2015 Mar-Apr;14(2):111-7
pubmed: 25127123